G. Harrison

发表

Impact of karyotype on treatment outcome in acute myeloid leukemia.

D. Grimwade, A. Moorman, A. Burnett, 2004, Annals of hematology.

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980–1997

S. Richards, O. Eden, J. Lilleyman, 2000, Leukemia.

Intraocular relapse of childhood acute lymphoblastic leukaemia

T. Somervaille, A. Vora, J. Lilleyman, 2002, British journal of haematology.

Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma.

M. Gore, P. Lorigan, N. Thatcher, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia

M. Pallis, J. Turzanski, S. Langabeer, 1999, British journal of haematology.

CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials.

R. Peto, S. Richards, G. Masera, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia.

K. Wheatley, R. Stevens, G. Harrison, 2001, Blood.

Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone

R. Gray, R. Zittoun, A. Burnett, 1999, Cancer.

Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990–99

K. Wheatley, G. Harrison, I. Hann, 2002, British journal of haematology.

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.

S. Richards, O. Eden, J. Lilleyman, 2000, Leukemia.

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

K Wheatley, D. Grimwade, C. Harrison, 1998, Blood.

Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial

K. Wheatley, G. Harrison, I. Hann, 1999, Leukemia.

The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial.

D. Grimwade, A. Goldstone, A. Burnett, 1999 .

Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph+) acute lymphoblastic leukaemia (ALL). Results from the international ALL trial (MRC UKALLXII/ECOG E2993)

M. Tallman, S. Richards, H. Prentice, 2001 .

CNS-Directed T herapy f or C hildhood A cute L ymphoblastic Leukemia: C hildhood A LL C ollaborative G roup O verview o f 4 3 Randomized T rials

R. Peto, S. Richards, G. Masera, 2003 .

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL Rl trial

S. Lawson, O. Eden, G. Harrison, 2005 .

Detection of minimal residual disease (MRD) in APL by "real-time" RT-PCR: Analysis of cases entered into the UK MRC ATRA trial.

A. Wheatley, D. Grimwade, E. Solomon, 1999 .

Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA

Hall, H. Prentice, Xa, 1997, British journal of haematology.

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

A. Goldstone, A. Burnett, K. Wheatley, 2002, British journal of haematology.

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

D. Grimwade, C. Harrison, A. Goldstone, 2001, Blood.

Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI

S. Richards, F. Hill, G. Harrison, 2002, British journal of haematology.

Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia

S. Richards, F. Hill, E. Morris, 2003, British Journal of Haematology.

Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment

S. Richards, F. Hill, G. Harrison, 2001, Archives of disease in childhood.

Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol

S. Richards, A. Vora, O. Eden, 2001, British journal of haematology.

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party.

S. Richards, S. Lawson, O. Eden, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X

G. Harrison, J. Chessells, C. Bailey, 1997, British journal of haematology.

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party

H. Kempski, K. Wheatley, G. Harrison, 2002, Leukemia.

Improved outcome of acute myeloid leukaemia in Down’s syndrome

K. Wheatley, G. Harrison, I. Hann, 1999, Archives of disease in childhood.

EVI1 expression in acute myeloid leukaemia

B. Bain, S. Langabeer, D. Grimwade, 2001, British journal of haematology.

Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial.

R. Gray, D. Grimwade, C. Harrison, 1996 .

Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL trial (MRC UKALL XII/ECOG E2993).

M. Tallman, S. Richards, H. Lazarus, 2001 .

Philadelphia chromosome plus ve patients with adult acute lymphoblastic leukaemia (ALL), early results from the international ALL trial (MRC UKALL-XII/ECOG E2993).

D. Neuberg, M. Tallman, S. Richards, 1999 .

The outcome of 551 1(st) CR transplants in adult ALL from the UKALL XII/ECOG 2993 study

M. Tallman, S. Richards, R. Chopra, 2004 .

Treatment of high risk leukaemia - Results of MRC childhood acute lymphoblastic leukaemia study MRC HR-1.

S. Richards, G. Harrison, S. Kinsey, 2002 .

The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the Medical Research Council UKALLR1 study

Richards, S. Richards, O. Eden, 2000, British journal of haematology.

Relationships between age at diagnosis, clinical features and outcome of therapy in children treated in the Medical Research Council trials for acute myeloid leukemia AML 10 and 12.

K. Wheatley, R. Stevens, G. Harrison, 2000 .